|
Online Database of Chemicals from Around the World | Search | Submit | Advertise | |
Home >> Chemical Listing >> ENMD-1198>> Market Analysis Reports |
Market Analysis Reports of ENMD-1198 |
|
EntreMed Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... trials for cancer, and ENMD-1198, an antimitotic agent in Phase 1 studies ... of investigation by EntreMed scientists. ENMD-1198 for Oncology: ENMD-1198 is a potent, orally-active ... apoptosis in tumor cells. Additionally, ENMD-1198 decreases the activity of three ... |